60%+ returns in 2025: Here’s how AI-powered stock investing has changed the game
FRANKFURT - Fresenius Medical Care AG announced Monday it has launched a €500 million fixed-rate bond offering due November 24, 2030, as part of its Debt Issuance Programme.
The five-year notes will be listed on the Luxembourg Stock Exchange, according to a press release statement. The healthcare company has appointed Commerzbank AG as the stabilization coordinator for the offering.
Several financial institutions will serve as stabilizing managers, including Commerzbank AG, BofA Securities Europe SA, Mizuho Bank Europe N.V., and Société Générale SA. The stabilization period is expected to begin today and last no longer than 30 days after the proposed issue date.
The stabilizing managers may over-allot securities to the extent permitted by applicable law and may conduct transactions to support the market price of the securities during the stabilization period. However, the company noted that stabilization may not necessarily occur and any action, if begun, may cease at any time.
The bonds will be issued in denominations of €100,000. The offer price has not yet been disclosed.
Fresenius Medical Care, a global provider of products and services for individuals with renal diseases, is using its existing Debt Issuance Programme for this offering.
The company emphasized that the announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for, or otherwise acquire or dispose of any securities in any jurisdiction.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.